Basic Information
| LncRNA/CircRNA Name | TUG1 |
| Synonyms | NA |
| Region | GRCh38_22:30969245-30979395 |
| Ensemble | ENSG00000253352 |
| Refseq | NR_002323 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | pancreatic cancer |
| ICD-0-3 | C25 |
| Methods | qPCR, RIP |
| Sample | PC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | The findings suggest that the abnormally high expression of TUG1 in PC tissues was associated with tumor size and pathological stage. |
| Pubmed ID | 30787623 |
| Year | 2019 |
| Title | Overexpressed long noncoding RNA TUG1 affects the cell cycle, proliferation, and apoptosis of pancreatic cancer partly through suppressing RND3 and MT2A. |
External Links
| Links for TUG1 | GenBank HGNC NONCODE |
| Links for pancreatic cancer | OMIM COSMIC |